# TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

> **NCT07242417** · EARLY_PHASE1 · RECRUITING · sponsor: **Beijing GoBroad Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Solid Cancer
- GPC3 Positive Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** TC-G203 cells treatment

## Key facts

- **NCT ID:** NCT07242417
- **Lead sponsor:** Beijing GoBroad Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-18
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-11-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07242417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07242417, "TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07242417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*